Description
Raltegravir is a potent integrase (IN) inhibitor used as an antiretroviral medication for the treatment of HIV infections.
Synonyms
Isentress; MK-0518; MK 0518; MK0518
IUPAC Name
N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
Molecular Formula
C20H21FN6O5
Canonical SMILES
CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F
InChI
InChI=1S/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30)
InChIKey
CZFFBEXEKNGXKS-UHFFFAOYSA-N
Melting Point
>122°C (dec.)
Solubility
In Vitro: DMSO: ≥ 100 mg/mL (225.01 mM)
Appearance
White to Off-white Powder
Application
Pyrrolidinones